
|Articles|May 30, 2019
Evidera to Acquire Medimix
Advertisement
Evidera has entered into an agreement to acquire Medimix International. The acquisition will enable Evidera to offer its customers technology solutions, real-world data, and access to health care providers.
For more on the acquisition, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
2
Is Artificial Intelligence Coming for Clinical Research?
3
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
4
The CRA Role’s Co-evolution With Clinical Trial Technology
5






.png)



.png)



.png)
.png)
